Publications & News

WilmerHale Reps Decibel Therapeutics in Strategic Collaboration With Regeneron

December 15, 2017

On November 29, 2017, Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Decibel Therapeutics, Inc. announced a collaboration to discover and develop new potential therapeutics to protect, repair and restore hearing.

WilmerHale's representation of Decibel Therapeutics was led by Steven Singer, Lia Der Marderosian, Kaylan Sliney and Alex Civetta.

Read Decibel's press release to learn more.